CDK1 and cancer: To measure the synergy of BETis and CDK1 inhibitors in killing these cancer cells, MDA-MB-231 cells were treated with varying concentrations of (+)-JQ1 and the CDK1 inhibitor RO-3306 individually or in combination, and cell viability was measured.